Here is the full overview for:
💊 Lamivudine + Nevirapine + Stavudine Tablet
Each tablet contains:
- Lamivudine (A) – 150 mg
- Nevirapine (B) – 200 mg
- Stavudine (C) – 30 mg
🧪 Nature / Drug Class
🔹 Fixed-Dose Combination Antiretroviral (ARV)
🔹 Drug classes:
- Lamivudine & Stavudine: NRTIs (Nucleoside Reverse Transcriptase Inhibitors)
- Nevirapine: NNRTI (Non-Nucleoside Reverse Transcriptase Inhibitor)
🩺 Purpose / Indications
✅ Treatment of HIV-1 infection in adults and adolescents
✅ Part of first-line ART in earlier national programs
✅ Reduces viral load and increases CD4 count
✅ Often used in resource-limited settings due to cost-effectiveness
⚙️ Advantages
✔️ Triple-drug combination – simplifies treatment
✔️ Enhances patient adherence
✔️ Offers effective viral suppression
✔️ Available as once or twice daily dosing depending on protocol
📦 Common Packaging
📦 Usually available in blister strips or plastic bottles
🧴 Solid oral tablet form, taken with or without food
🕒 Typical dose: 1 tablet twice daily (verify with current guidelines)
⚠️ Patient Advice / Precautions
🧪 Regular liver function monitoring – Nevirapine may cause hepatotoxicity
🦶 Monitor for peripheral neuropathy (Stavudine)
🩸 Check for anemia/neutropenia (Lamivudine side effects)
📛 Rash and hypersensitivity may occur (especially in early weeks)
📆 Maintain strict adherence to avoid resistance
🚭 Avoid alcohol and hepatotoxic drugs
🚫 Contraindications / Cautions
❌ Allergy to any active ingredient
⚠️ Use caution in:
- Liver impairment
- History of pancreatitis or peripheral neuropathy
- Pregnancy (due to Stavudine risks)
🧊 Storage
🌡️ Store below 25°C
💊 Protect from moisture and light
🔐 Keep out of reach of children